drugIndia
Cart
Glycomet Trio 2 Tablet SR

Glycomet Trio 2 Tablet SR

Metformin (500mg) + Glimepiride (2mg) + Voglibose (0.2mg)

USV Ltd
Laxative
169.20211.5020% OFF
In Stock
1
Safe & Secure
Easy Returns
24/7 Support
Delivery
drugIndia verified
Save 74%
Best Alternative100% Match

Ozomet-VG2 Tablet SR

Ozone Pharmaceuticals Ltd

Voglibose 0.2mg
Ozomet-VG2 Tablet SR

Pack Size

1 units

Price

43.8420% off
Ozomet-VG2 Tablet SR is 100% same as Glycomet Trio 2 Tablet SR
Better ValueSame QualitySame Effectiveness

Save ₹125

that's 74% off!

composition
  1. Voglibose 0.2mg
  2. Glimepiride 2mg
  3. Metformin 500mg
Buy Now
169.2020% OFF
211.50

About This Medicine

Product description & overview

Glycomet Trio 2 Tablet SR: A Combined Approach to Blood Sugar Control

Glycomet Trio 2 Tablet SR is a combination medication used to manage type 2 diabetes by reducing blood sugar levels in adults. It combines three active ingredients:

* Glimepiride (2mg): Helps lower blood sugar levels by stimulating the release of insulin from the pancreas.
* Metformin (500mg): Improves insulin sensitivity, allowing cells to utilize glucose more effectively.
* Voglibose (0.2mg): Delays the absorption of glucose into the bloodstream, further reducing blood sugar spikes.

This tablet is designed for once-daily use and provides a comprehensive approach to blood sugar management. It's important to consult your healthcare provider before starting or changing any medication regimen.

Remember that consistent usage and proper diet are crucial alongside this medication for optimal results. Always follow your doctor's instructions and maintain open communication with them about your progress and any concerns you may have.

Important: This information is provided for general knowledge purposes only. It should not be considered a substitute for professional medical advice or treatment. Consult your physician or pharmacist for further information and guidance.

Active composition

Metformin 500 mg

+2 more active ingredients

About Metformin

Metformin is an oral antihyperglycemic agent used to manage type 2 diabetes mellitus. It works by decreasing glucose production in the liver and improving insulin sensitivity. Metformin is effective in controlling blood sugar levels and preventing diabetes-related complications. In summary, Metformin is vital for managing type 2 diabetes.

How It Works

Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.

Medicine Strength
500 mg

All Active Ingredients

Metformin500 mg
Glimepiride2 mg
Voglibose0.2 mg

Glimepiride

Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.

Voglibose

Voglibose inhibits intestinal alpha-glucosidases, delaying carbohydrate digestion and absorption, thus lowering postprandial glucose levels.

Dosage & How to Use

Dosage information not available. Please consult your doctor or pharmacist.

Safety Advice

Important precautions

Side Effect Occurrence

Based on clinical trials and patient reports.

Overall Tolerance

Most patients tolerate well

Only 2.3% reported effects

Common Side Effects

Headache8%
Nausea5%
Dizziness3%
Fatigue2%
Rash1%
Higher
Lower

Safety Advice

Alcohol

It is unsafe to consume alcohol with Glycomet Trio 2 Tablet SR.

High Risk

Pregnancy

Glycomet Trio 2 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Medical Advice

Driving

Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.

Exercise Caution

Liver

Glycomet Trio 2 Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Glycomet Trio 2 Tablet SR may be needed. Please consult your doctor. Glycomet Trio 2 Tablet SR is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.

Regular Checkup

Breastfeeding

Glycomet Trio 2 Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.

Consult Doctor

Kidney

Glycomet Trio 2 Tablet SR is probably unsafe to use in patients with kidney disease and should be avoided. Please consult your doctor. Use of Glycomet Trio 2 Tablet SR is, however, not recommended in patients with severe kidney disease.

Regular Checkup

Customer Reviews

0 reviews for Glycomet Trio 2 Tablet SR

Products matching your search